Literature DB >> 27264729

High glucose levels affect spermatogenesis: an in vitro approach.

Renata S Tavares1, Joana M D Portela1, Maria I Sousa1, Paula C Mota1, João Ramalho-Santos1, Sandra Amaral1.   

Abstract

Besides known factors that may cause male infertility, systemic diseases such as diabetes mellitus may further exacerbate a decline in male fertility. This metabolic disease, clinically characterised by a hyperglycaemic phenotype, has devastating consequences in terms of human health, with reproductive dysfunction being one of the associated clinical complications. Nonetheless, the mechanisms responsible for such alterations are still poorly understood due to the multiplicity of factors involved in the induced pathophysiological changes. With this in mind, we focused on the main mediator of diabetes-associated alterations and performed an in vitro approach to address the effects of high glucose conditions on spermatogenesis, avoiding other confounding in vivo factors. Mouse (5 days post partum) testis fragments were cultured on agar gel stands at a gas-liquid interface with either 5, 25 or 50mM D-glucose for 3 weeks. Stereological analysis revealed that high D-glucose levels increased Sertoli cell number (P<0.05) and decreased tubular luminal area (P<0.01), suggesting an impairment of this somatic cell type. Moreover, higher proliferative activity in a TM4 Sertoli cell line exposed to high D-glucose was found (P<0.05) without compromising cell viability (P>0.05), further suggesting altered Sertoli cell maturation. Overall, high D-glucose concentrations may lead to impairment of Sertoli cell function, which, given their significant role in spermatogenic control, may compromise male fertility.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27264729     DOI: 10.1071/RD15475

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  2 in total

1.  Effect of spermidine on ameliorating spermatogenic disorders in diabetic mice via regulating glycolysis pathway.

Authors:  Jin-Yuan Wang; Duo Ma; Min Luo; Yong-Peng Tan; Ge Tian; Yong-Ting Lv; Mei-Xiang Li; Xi Chen; Zhi-Han Tang; Lin-Lin Hu; Xiao-Can Lei
Journal:  Reprod Biol Endocrinol       Date:  2022-03-07       Impact factor: 5.211

2.  Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome.

Authors:  Qingkui Jiang; Constanze C Maresch; Sebastian Friedrich Petry; Agnieszka Paradowska-Dogan; Sudhanshu Bhushan; Yongsheng Chang; Christine Wrenzycki; Hans-Christian Schuppe; Petr Houska; Michaela F Hartmann; Stefan A Wudy; Lanbo Shi; Thomas Linn
Journal:  JCI Insight       Date:  2020-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.